A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease
Clinical trial NCT06557772 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06557772
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-29
- Primary completion
- 2026-08-05
- Enrollment
- 229
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.